GSK3α inhibitor and method of use thereof

JP2026518618APending Publication Date: 2026-06-09BLUEPRINT MEDICINES CORP

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
BLUEPRINT MEDICINES CORP
Filing Date
2024-05-10
Publication Date
2026-06-09

Smart Images

  • Figure 2026518618000001_ABST
    Figure 2026518618000001_ABST
Patent Text Reader

Abstract

TIFF2026518618000325.tif131161 discloses compounds and compositions that inhibit GSK3α, represented by formula (I') or (X), and pharmaceutically acceptable salts thereof. The variables in formula (I') or (X) are defined herein. Also disclosed are methods for treating cancer in subjects using the disclosed GSK3α inhibitors.
Need to check novelty before this filing date? Find Prior Art